These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5170618)

  • 1. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of guancydine on blood pressure, vascular reactivity, and norepinephrine uptake in essential hypertension.
    Russo C; Mendlowitz M
    Clin Pharmacol Ther; 1972; 13(6):875-8. PubMed ID: 4673232
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxyguanidines. A new class of antihypertensive agents.
    Bailey DM; DeGrazia CG
    J Med Chem; 1973 Feb; 16(2):151-6. PubMed ID: 4683110
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute effects of bethanidine on arterial pressure and on urinary excretion of catecholamines in patients with essential hypertension].
    Fabris F; Mathis I; Rappelli A; Gagna C
    Boll Soc Ital Biol Sper; 1968 Feb; 44(4):320-4. PubMed ID: 5677880
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of guancydine on systemic and renal hemodynamics in arterial hypertension.
    Villarreal H; Arcila H; Ramirez MA
    Clin Pharmacol Ther; 1971; 12(5):838-42. PubMed ID: 4936149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the action of the antihypertensive agent guancydine. II. Potentiation of the effect by pretreatment with furosemide or mefruside in the rat].
    Vetter W; Armbruster H; Fischer N; Schweikert HU; Vetter H; Werning C; Siegenthaler W
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(1):11-22. PubMed ID: 5143296
    [No Abstract]   [Full Text] [Related]  

  • 10. Guancydine, a new hypotensive agent with complex action.
    Hărăgus ST; Uza G; Duncea C
    Cor Vasa; 1977; 19(3):214-9. PubMed ID: 562730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guancydine. Clinical evaluation of a new hypotensive agent].
    da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C
    Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action on the arterial pressure of a new antihypertensive agent (LD 3598) injected by the intramuscular route].
    Lagrue G; Giudicelli R; Boccon-Gibod L; Milliez P
    Presse Med (1893); 1966 Nov; 74(49):2535-6. PubMed ID: 5920840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative determination of the efficacy of antihypertensive agent combinations].
    Stoepel K; Kaller H; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):189-96. PubMed ID: 4239710
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of the newer antihypertensive agents].
    Rahn KH
    Internist (Berl); 1983 Mar; 24(3):128-34. PubMed ID: 6347939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.